Transkaryotic Therapies extends greenshoe exercise period

New York, June 1 - Transkaryotic Therapies Inc. said it extended the period in which the underwriters of its recent offering of $90 million senior convertible notes due 2011 can exercise the $10 million greenshoe to 45 days after the date of the offering from 30 days.

The Cambridge, Mass.-based pharmaceutical company priced the convertibles after the close on April 28 to yield 1.25% with a 22.5% initial conversion premium via sole bookrunner J.P. Morgan Securities.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.